Lili Su
Fujian Provincial Key Laboratory Of Tumor Biotherapy
Fuzhou, 350014, China
Fuzhou, 350014, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
FRET-based hypoxia-responsive self-quenching BODIPY nanoparticles enhance lung cancer efficacy while avoiding skin toxicity.
Journal: Bioorganic chemistry
Published: April 26, 2026
BEZ235 enhances the photodynamic antitumor efficacy of hypoxia-responsive BODIPY prodrug nanoparticles by inhibiting the PI3K/mTOR pathway and alleviating hypoxia.
Journal: Colloids and surfaces. B, Biointerfaces
Published: January 01, 2026
Erythrabyssin ll is identified as a late-stage autophagy inhibitor reversing chemoresistance and promoting apoptosis in ovarian cancer.
Journal: iScience
Published: August 14, 2024
RanBP2/Nup358 Mediates Sumoylation of STAT1 and Antagonizes Interferon-α-Mediated Antiviral Innate Immunity.
Journal: International journal of molecular sciences
Published: November 15, 2023
SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: September 18, 2023
Plant and animal positive-sense single-stranded RNA viruses encode small proteins important for viral infection in their negative-sense strand.
Journal: Molecular plant
Published: February 03, 2023
Lower Somatic Mutation Levels in the λ Light-Chain Repertoires with Chronic HBV Infection.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: January 07, 2021
Decrease of Clone Diversity in IgM Repertoires of HBV Chronically Infected Individuals With High Level of Viral Replication.
Journal: Frontiers in microbiology
Published: October 09, 2020
Molecular regulation and clinical significance of caveolin-1 methylation in chronic lung diseases.
Journal: Clinical and translational medicine
Published: February 23, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026